About SkyePharma (LON:SKP)
Skyepharma Ltd, formerly Skyepharma PLC, is a drug delivery company engaged in the development of oral and inhalation products. The Company operates as an independent developer of complex pharmaceutical products for global markets. Its principal activities are the generation and development of product and drug delivery technology concepts, involving the application of its inhalation and oral technologies. It operates through the segment of development and supply of pharmaceutical products. It is also involved in the supply of products to its marketing partners, as in the case for flutiform and over seven oral products manufactured in its Lyon Facility. It operates primarily for respiratory applications. Its inhalation products include Relvar Ellipta/Breo Ellipta, Anoro Ellipta and Incruse Ellipta. Its oral products include RAYOS/LODOTRA, Requip Once-a-day, Xatral/Uroxatral, Madopar DR/Prolopa, Sular, ZYFLO CR, Paxil CR, Diclofenacratiopharm Uno, Triglide and Coruno.
Industry, Sector and Symbol
Trailing P/E Ratio1776
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Trailing EPSGBX 0.25
Return on Equity79.41%
Return on Assets35.64%
SkyePharma (LON:SKP) Frequently Asked Questions
What is SkyePharma's stock symbol?
SkyePharma trades on the London Stock Exchange (LON) under the ticker symbol "SKP."
Who are some of SkyePharma's key competitors?
Some companies that are related to SkyePharma include Lannett (LCI), CoLucid Pharmaceuticals (CLCD), Amphastar Pharmaceuticals (AMPH), Collegium Pharmaceutical (COLL), SciClone Pharmaceuticals (SCLN), AMAG Pharmaceuticals (AMAG), Corium International (CORI), Aceto (ACET), Tetraphase Pharmaceuticals (TTPH), Neos Therapeutics (NEOS), Marinus Pharmaceuticals (MRNS), Aquinox Pharmaceuticals (AQXP), Celsius (CELH), Teligent (TLGT), Allergy Therapeutics (AGY), BioDelivery Sciences International (BDSI), Adamis Pharmaceuticals (ADMP) and Diurnal Group (DNL).
How do I buy SkyePharma stock?
Shares of SkyePharma and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is SkyePharma's stock price today?
One share of SkyePharma stock can currently be purchased for approximately GBX 444.
How big of a company is SkyePharma?
SkyePharma has a market capitalization of £470.25 million.
How can I contact SkyePharma?
SkyePharma's mailing address is 46-48 Grosvenor Gardens, LONDON, SW1W 0EB, United Kingdom. The company can be reached via phone at +44-20-78810524.
MarketBeat Community Rating for SkyePharma (SKP)MarketBeat's community ratings are surveys of what our community members think about SkyePharma and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Earnings History for SkyePharma (LON:SKP)
No earnings announcements for this company have been tracked by MarketBeat.com
SkyePharma (LON:SKP) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for SkyePharma (LON:SKP)
No dividend announcements for this company have been tracked by MarketBeat.com
SkyePharma (LON SKP) Insider Trading and Institutional Ownership History
SkyePharma (LON SKP) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
SkyePharma (LON SKP) News Headlines
SkyePharma (LON:SKP) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
SkyePharma (LON SKP) Stock Chart for Wednesday, January, 17, 2018